Trial · NCT04969991
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Proportion of Participants Alive and Free of Respiratory Failure at Day 28 | Baseline to Day 28 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Subjects Using HFNC Within the First 28 Days After Randomization | From randomization through Day 28 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Subjects Using Noninvasive Respiratory Support Within the First 28 Days After Randomization | From randomization through Day 28 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Subjects Using Mechanical Ventilation Within the First 28 Days After Randomization | From randomization through Day 28 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Days of Oxygen Support Through Day 28 After Randomization | From randomization through Day 28 | days | MEAN | |
| SECONDARY | Proportion of Participants Remaining Free of Mechanical Ventilation or ECMO Throughout the 28 Days After Randomization | From randomization through Day 28 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Subjects With All-cause Mortality Through Day 60 | From randomization through Day 60 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Change in Body Temperature | From providing informed consent through Day 60 | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Participant-reported Quality-of-life Assessment Using the 12-item Short Form Survey (SF-12) at Day 28 After Randomization | Day 28 | |||
| OTHER_PRE_SPECIFIED | Activity of sPLA2 Within Blood Samples Collected as Clinically Required From Treatment Initiation to Day 28 After Randomization | From treatment initiation through Day 28 | |||
| OTHER_PRE_SPECIFIED | Changes in PK Parameters: Area-under-the-curve (AUC) | Day 1 through Day 3 | |||
| OTHER_PRE_SPECIFIED | Changes in PK Parameters: Maximum Concentration (Cmax) | Day 1 through Day 3 | |||
| OTHER_PRE_SPECIFIED | Changes in PK Parameters: Time of Cmax (Tmax) | Day 1 through Day 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04969991/outcomes